Plasma β-endorphin during clinical and experimental ischaemic pain

References

• Cox B M, Goldstein A, Li C H. Opioid activity of a peptide, β-lipotropin (61–91), derived from β-lipotropin. Proc Natl Acad Sci 1976; 73: 1821–3
   PubMed Web of Science ®Google Scholar
• Nakanishi S, Inoue A, Kita T, Nakamura M, Chang A CY, Cohen S N, Numa S. Nucleotide sequence of cloned cDNA for bovine corticotropin-β-lipotropin precursor. Nature 1979; 278: 423–7
   PubMed Web of Science ®Google Scholar
• Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F. β-Endorphin and Adrenocorticotropin are sereted concomitantly by the pituitary gland. Science 1977; 197: 1367–9
   PubMed Web of Science ®Google Scholar
• Akil H, Watson S J, Young E, Lewis M E, Khachaturian H, Walker J M. Endogenous opioids: Biology and function. Ann Rev Neurosci 1984; 7: 223–55
   PubMed Web of Science ®Google Scholar
• Bramnert M, Ekman R, Larsson I, Thorell J I. Characterization and application of a radioimmunoassay for β-endorphin using an antiserum with negligible cross-reactivity against β-lipotropin. Regul Pept 1982; 5: 65–75
   PubMedGoogle Scholar
• Affinity Chromatography. Principles and Methods. Pharmacia Fine Chemicals 1979
   Google Scholar
• Morris B J. Specific radioactivity of radioimmunoassay tracer determined by self-displacement: A re-evaluation. Clin Chim Acta 1976; 73: 213–6
   PubMed Web of Science ®Google Scholar
• Bach F W, Jensen K, Blegvad N, Fenger M, Jordal R, Olesen J. β-endorphin and ACTH in plasma during attacks of common and classic migraine. Cephalalgia 1985; 5: 177–82
   Google Scholar
• Chahine R A. Unstable angina. The problem of definition. Br Heart J 1975; 37: 1246–9
   Google Scholar
• Ekins R, Newman B. Theoretical aspects of saturation analysis. Acta Endocrinol (Copenh) 1970, suppl. 147: 11–37
   Google Scholar
• Vuolteenaho O. β-endorphin related peptides in the human pituitary. Isolation and characterization of major immunoreactive peptides inclusive former unrecognized β-endorphin 1–18. Acta Physiol Scand 1984, suppl 531
   Google Scholar
• Wiedemann K, Teschemacher H. β-endorphin immunoreactive materials in human plasma determined by a multiple radioimmunoassay system. Life Sci 1983, suppl. I: 89–92
   Google Scholar
• Bruni J F, Watkins W B, Yen S SC. β-endorphin in the human pancreas. J Clin Endocrinol Metab 1979; 49: 649–51
   PubMed Web of Science ®Google Scholar
• Tari A, Miyachi Y, Hide M, Sumii K, Kajiyama G, Tohara E, Tanaka K. β-endorphin like immunoreactivity in normal gastric mucosa, muscle layer, and adenocarcinoma. Gastroenterology 1985; 88: 670–4
   Google Scholar
• Rosenquist G L, Maruthainar K, Smyth D G. β-endorphin is present in active and inactive forms in rat gastric antrum. Biochem Biophys Res Commun 1986; 134: 14–20
   Google Scholar
• Nakao K, Nakai Y, Oki S, Horii K, Imura H. Presence of immunoreactive β-endorphin in normal human plasma. A concomitant release of β-endorphin with adrenocorticotropin after metyrapone administration. J Clin Invest 1978; 62: 1395–98
   PubMedGoogle Scholar
• Wardlaw S L, Frantz A G. Measurement of β-endorphin in human plasma. J Clin Endocrinol Metab 1979; 48: 176–80
   PubMed Web of Science ®Google Scholar
• Laatikainen T, Salminen K, Stenman U-H, Leppäluoto J. Determination of plasma β-endorphin and β-lipotropin by cation-exchange liquid chromatography and radio-immunoassay. Clin Chem 1985; 31: 134–6
   PubMed Web of Science ®Google Scholar
• Yamaguchi H, Liotta A S, Krieger D T. Simultaneous determination of human plasma immunoreactive β-lipotropin, γ-lipotropin and β-endorphin using immune affinity chromatography. J Clin Endocrinol Metab 1980; 51: 1002–8
   PubMedGoogle Scholar
• Höllt V, Müller O A, Fahlbusch R. β-Endorphin in human plasma: Basal and pathologically elevated levels. Life Sci 1979; 25: 37–44
   Google Scholar
• Wilkes M M, Stewart R D, Bruni J F, Quigley M E, Yen S SC, Ling N, Cretien M. A specific homologous radioimmunoassay for human β-endorphin: Direct measurement in biological fluids. J Clin Endocrinol Metab 1980; 50: 309–15
   Google Scholar
• Güllner H, Nicholson W E, Wilson M G, Bartter F C, Orth D N. The response of plasma immunoreactive adrenocorticotropin, β-endorphin/β-lipotropin, γ-lipotropin and Cortisol to experimentally induced pain in normal subjects. Clin Sci 1982; 63: 397–400
   PubMed Web of Science ®Google Scholar
• Pertovaara A, Kemppainen P, Johanson G, Karonen S. Ischemic pain nonsegmentally produces a predominant reduction of pain and thermal sensitivity in man. A selective role for endogenous opioids. Brain Res 1982; 251: 83–92
   PubMed Web of Science ®Google Scholar
• Pasi A, Moccetti T, Legler M, Müeller J, Foletta D, Gramsch C, Hartmann H. Elevation of blood levels of β-endorphin-like immunoreactivity in patients with shock. Res Commun Chem Pathol Pharmacol 1983; 42: 509–12
   Google Scholar
• Holaday J W. Cardiovascular consequences of endogenous opiate antagonism. Biochem Pharmacol 1983; 32: 573–85
   PubMed Web of Science ®Google Scholar
• Bennett T L, Pearson J W, Frederickson R CA. Plasma endorphin-like immunoreactivity in pelvic and abdominal pain. Pain 1986; 24: 41–8
   Google Scholar
• Cohen M R, Pickar D, Dubois M, Bunney W E, Jr. Stress-induced plasma β-endorphin immunoreactivity may predict postoperative morphine usage. Psychiatry Res 1982; 6: 7–12
   PubMed Web of Science ®Google Scholar
• Wilier J C, Sheng-Shu L, Bertagna X, Girard F. Pituitary β-endorphin not involved in pain control in some pathophysiological conditions. Lancet 1984; 2: 295–6
   Google Scholar
• Stoupel E, Pinchas A, Gilad I, Laron Z, Agmon J. β-endorphins in acute myocardial infarction. Clin Cardiol 1986; 9: 409–12
   Google Scholar